J Gen Virol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published as JGV in Press, 10.1099/vir.0.012724-0 on July 8, 2009 J Gen Virol 90 (2009), 2569-2574; DOI 10.1099/vir.0.012724-0

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplementary table
Right arrow All Versions of this Article:
vir.0.012724-0v1
90/10/2569    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Saunders, G. C.
Right arrow Articles by Lantier, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saunders, G. C.
Right arrow Articles by Lantier, F.
Agricola
Right arrow Articles by Saunders, G. C.
Right arrow Articles by Lantier, F.

Short Communication

Protective effect of the T112 PrP variant in sheep challenged with bovine spongiform encephalopathy

G. C. Saunders1, I. Lantier2, S. Cawthraw1, P. Berthon2, S. J. Moore3, M. E. Arnold4, O. Windl1, M. M. Simmons3, O. Andréoletti5, S. Bellworthy3 and F. Lantier2

1 Molecular Pathogenesis and Genetics Department, Veterinary Laboratories Agency (VLA Weybridge), New Haw, Addlestone, Surrey KT15 3NB, UK
2 INRA, UR1282, Infectiologie Animale et Santé Publique, F-37380 Nouzilly, France
3 Pathology Department, VLA Weybridge, New Haw, Addlestone, Surrey KT15 3NB, UK
4 CERA, VLA Weybridge, New Haw, Addlestone, Surrey KT15 3NB, UK
5 UMR INRA-ENVT, Interactions Hôtes–Agents Pathogènes, Ecole Vétérinaire de Toulouse, F-310761 Toulouse, France

Correspondence
S. Cawthraw
s.cawthraw{at}vla.defra.gsi.gov.uk


   ABSTRACT
TOP
ABSTRACT
MAIN TEXT
REFERENCES
 
Sheep with an ARQ/ARQ PRNP genotype at codon positions 136/154/171 are highly susceptible to experimental infection with bovine spongiform encephalopathy (BSE). However, a number of sheep challenged orally or intracerebrally with BSE were clinically asymptomatic and found to survive or were diagnosed as BSE-negative when culled. Sequencing of the full PRNP gene open reading frame of BSE-susceptible and -resistant sheep indicated that, in the majority of Suffolk sheep, resistance was associated with an M112T PRNP variant (TARQ allele). A high proportion (47 of 49; 96 %) of BSE-challenged wild-type (MARQ/MARQ) Suffolk sheep were BSE-infected, whereas none of the 20 sheep with at least one TARQ allele succumbed to BSE. Thirteen TARQ-carrying sheep challenged with BSE are still alive and some have survival periods equivalent to, or greater than, reported incubation periods of BSE in ARR/ARR and VRQ/VRQ sheep.

A supplementary table detailing the ovine PRNP ORF PCR amplification conditions used is available with the online version of this paper.


   MAIN TEXT
TOP
ABSTRACT
MAIN TEXT
REFERENCES
 
Bovine spongiform encephalopathy (BSE) belongs to a group of diseases known as transmissible spongiform encephalopathies (TSEs) or prion diseases, which include scrapie in sheep and goats and Creutzfeldt–Jakob disease (CJD) in humans. BSE was first identified in cattle in the UK in 1985 (Wells et al., 1987Down) and has since been reported in at least 25 countries (http://www.oie.int/Eng/Info/en_esbmonde.htm). Consumption of BSE-infected foodstuffs has been shown to be a significant risk factor for the development of variant CJD (vCJD) in humans (Will et al., 1996Down; Ward et al., 2006Down) and the biological similarity of BSE and vCJD is now well-established (Collinge et al., 1996Down; Bruce et al., 1997Down; Hill et al., 1997Down).

Sheep may have been exposed to BSE through the same infected meat and bonemeal feed source that is thought to have been responsible for maintaining the BSE epidemic in cattle (Wilesmith et al., 1992Down). Infectivity in BSE-infected cattle is largely confined to the central nervous system, but in experimental models of BSE in sheep the distribution of infectivity is similar to that of scrapie, with involvement of the lymphoreticular system, blood and central and peripheral nervous tissues (Houston et al., 2000Down; Foster et al., 2001aDown, bDown; Jeffrey et al., 2001Down; Hunter, 2003Down; Bellworthy et al., 2005aDown; Andréoletti et al., 2006Down; van Keulen et al., 2008Down). Therefore it is possible that, if BSE entered a sheep flock, lateral transmission may be more efficient than in cattle. To date, surveillance using biochemical tests that can discriminate between experimental ovine BSE and scrapie has failed to detect any evidence of naturally BSE-infected sheep (Thuring et al., 2004Down; Eloit et al., 2005Down; Sharpe et al., 2005Down; Stack et al., 2006Down), although there have been one confirmed case (Eloit et al., 2005Down) and one suspected case (Jeffrey et al., 2006Down) of natural BSE in goats. The risk to the human population of BSE in sheep requires further investigation and key to estimating such a risk is the calculation of the prevalence of BSE in sheep at any given point in time, which is in turn dependent on the susceptibility of sheep to the BSE agent and the efficiency of subsequent sheep-to-sheep and sheep-to-human passage (Baylis, 2002Down; Ferguson et al., 2002Down; Kao et al., 2002Down; Fryer et al., 2007Down). Inaccurate data on BSE-susceptible ovine genotypes could potentially have a significant effect on the assessment of risk of BSE in sheep to the human consumer (Kao et al., 2003Down).

As with scrapie, sheep with different PRNP genotypes have been shown to differ in their susceptibility to BSE (Foster et al., 2001aDown, bDown; Jeffrey et al., 2001Down; Houston et al., 2003Down; Andréoletti et al., 2006Down; Goldmann et al., 2006Down). The PRNP gene encodes the cellular prion protein (PrPC), which can undergo misfolding to a disease-associated scrapie form (PrPSc) thought to be an integral component of the infectious prion agent (Prusiner, 1982Down). The ovine PRNP open reading frame (ORF) is 256 codons in length; three codons, 136, 154 and 171, are the most commonly observed variable sites in the gene and can affect resistance and susceptibility to classical scrapie in sheep. The dimorphic codon 136 can be either valine (V) or arginine (A), codon 154 can be arginine (R) or histidine (H) and the polymorphic codon 171 is most commonly glutamine (Q), arginine (R) or histidine (H). The three-codon allele is usually expressed as, for example, VRQ and the genotype as VRQ/ARQ. Additional PRNP mutations are most commonly seen in association with the ARQ allele, thought to be the ancestral wild-type allele (Goldmann et al., 2005Down).

ARQ/ARQ sheep are considered to be highly susceptible to BSE (Goldmann et al., 1994Down; Foster et al., 2001aDown; Houston et al., 2003Down; van Keulen et al., 2008Down) and are therefore used frequently in experimental challenges of BSE, such as those undertaken at the VLA (UK) and the Institut National de la Recherche Agronomique (INRA, France). However, in the course of several independent studies, small numbers of ARQ/ARQ sheep were observed to be resistant to challenge with BSE, either by displaying an extended survival period or failing to develop disease. We analysed samples and data from these studies further to ascertain whether genetics could explain the divergent results.

Suffolk sheep of the ARQ/ARQ genotype were sourced from the Defra New Zealand-derived flock (Simmons et al., 2009Down) and Romney sheep from a scrapie-free flock closed since 1972, and were used in a range of BSE-transmission studies at the VLA and INRA. Sheep received either a 5 g oral dose or a 0.1 g (VLA) or 0.05 g (INRA) intracerebral (IC) dose of BSE-infected bovine or ovine brainstem as described previously (Bellworthy et al., 2005aDown; Andréoletti et al., 2006Down). Sheep were euthanized either at set time points or when they developed clinical disease. TSE diagnosis was carried out by immunohistochemistry, Western blotting and Bio-Rad Sheep and Goat ELISA on the brainstem (Gavier-Widén et al., 2005Down; Stack et al., 2006Down; Simmons et al., 2007Down).

The full ovine PRNP genotype was obtained by sequencing of the complete ORF of the PRNP gene as described previously (Saunders et al., 2006)Down for VLA samples and in Supplementary Table S1 (available in JGV Online) for INRA samples. For the purposes of this study, full PRNP ORF sequence data were obtained from BSE-dosed and control animals consisting of 97 Suffolk and 203 Romney breed ARQ/ARQ sheep housed at the VLA and 32 ARQ/ARQ INRA-based Suffolk sheep.

PRNP ORF sequencing revealed one additional polymorphism in the Suffolk-breed sheep and no PRNP polymorphisms in the Romney sheep. Suffolk animals were found to contain a mutation resulting in a methionine-to-threonine amino acid change at codon 112 (M112T), giving an M112ARQ (wild-type, shortened to MARQ) to T112ARQ (shortened to TARQ) variant.

In order to assess the effect of a particular PRNP allele on BSE susceptibility or resistance, a subset of BSE-dosed Suffolk sheep at VLA and INRA were selected from the various studies for further analysis. The animals selected included those inoculated experimentally with what could be considered an effective BSE dose (defined as ≥5 g bovine or ovine BSE via the oral route or ≥0.1 g bovine BSE or ≥0.05 g ovine BSE via the IC route for the purposes of this analysis) and those culled after BSE became biochemically detectable [≥600 days post-inoculation (p.i.) for the orally challenged 5 g bovine BSE timed-cull group]. Animals exposed to a low effective dose, culled before infection is detectable or exposed through ‘natural’ transmission (through contact with infected sheep or environment) are liable to result in a failure of transmitted infectivity in some animals due to factors that are independent of PRNP genetics. Therefore, data from 60 (35 MARQ/MARQ, 22 MARQ/TARQ and three TARQ/TARQ) of the 129 Suffolk animals genotyped, including some undosed control animals, were not utilized further.

The 69 Suffolk sheep selected and used to explore whether there is an association between PRNP genotype and BSE resistance and susceptibility are described in Table 1Down. Clinical disease was not observed in timed culls, end-of-experiment culls or intercurrent casualties.


View this table:
[in this window]
[in a new window]

 
Table 1. Summary of 69 Suffolk sheep challenged with an ‘effective’ BSE dose used to assess the proportion of sheep carrying a particular PRNP allele

Genotype shown is at PRNP codons 112, 136, 154 and 171. Abbreviations: EoE, end-of-experiment cull; IC, intracerebral; PO, per os (oral); TC, timed cull.

 
All 47 BSE-positive Suffolk sheep carried the MARQ/MARQ PRNP genotype (Table 2Down). Of the 22 sheep that were BSE-negative or were still alive at the end of the study, 17 carried one TARQ allele and three carried two TARQ alleles (Table 2Down). Using Fisher's exact test, there is a highly statistically significant association between PRNP genotype and disease outcome in Suffolk sheep (P<0.0001). Whilst the majority of resistant sheep carry at least one TARQ allele, there are two Suffolk sheep and numerous Romney sheep that exhibit BSE resistance in the absence of the TARQ allele. Therefore, some other, as-yet-unknown factor, potentially a non-coding region of the PRNP gene (Saunders et al., 2009Down), must be responsible in these cases.


View this table:
[in this window]
[in a new window]

 
Table 2. Summary of the proportion of BSE-dosed sheep carrying a particular PRNP genotype and associated with BSE susceptibility (BSE-positive) or resistance (alive/BSE-negative)

Data are given as no. sheep (percentage).

 
Fourteen BSE-challenged sheep were still alive at the time of writing (March 2009), 715–3495 days p.i. (Table 1Up); 13 of these carry at least one TARQ allele. The mean survival time is longer than the mean incubation period for a comparable BSE challenge in a MARQ/MARQ susceptible animal (Fig. 1Down).


Figure 1
View larger version (12K):
[in this window]
[in a new window]

 
Fig. 1. Mean incubation periods for BSE-positive and clinically affected MARQ/MARQ Suffolk sheep (shaded bars) and survival periods (as at March 2009) of BSE-dosed TARQ-carrying sheep (empty bars). Error bars represent ±1SD (n=17, 7, 2, 3, 3 for BSE-positive and n=3, 0, 3, 1, 6 sheep for survivors in the respective challenge groups from left to right).

 
A dose–response model used previously for an oral attack rate study of BSE (Wells et al., 2007Down) was fitted to each BSE-challenge group. In short, the model consists of a logistic-regression model for the probability of survival versus the log dose, but allowing for the possibility that the log-normal incubation period was longer than the time for which the animals have been observed. The model is fitted to the data by maximum likelihood and allows comparison of the impact of genotype on the dose–response via likelihood-ratio tests.

For sheep dosed orally with 5 g bovine BSE, a likelihood-ratio test showed that there was a statistically significant difference (P<0.001) between the dose–response of sheep with a MARQ/MARQ or a MARQ/TARQ genotype, with MARQ/TARQ animals having a low probability of being infected. The same result was obtained for combined 0.1 and 0.05 g IC ovine BSE-challenged animals, with non-MARQ/MARQ sheep having a low probability (P<0.001) of being infected. An almost significant difference (P=0.051) was obtained between MARQ/MARQ and MARQ/TARQ sheep in the IC bovine BSE-dosed group, with the MARQ/TARQ animals having a low probability of infection.

The M112T variant of the sheep PRNP gene has been reported previously in scrapie-free sheep (Ikeda et al., 1995Down; Heaton et al., 2003Down; Gombojav et al., 2004Down; Goldmann et al., 2005Down; Lan et al., 2006Down; Ohara et al., 2007Down; Serrano et al., 2007Down; Babar et al., 2009Down), sheep infected naturally with classical scrapie (Laplanche et al., 1993Down; Ikeda et al., 1995Down; Saunders et al., 2006Down; Vaccari et al., 2007Down), sheep challenged orally with scrapie (Laegreid et al., 2008Down) and in various breeds of sheep (Goldmann et al., 2005Down; Serrano et al., 2007Down; Babar et al., 2009Down). The Goldmann et al. (2005)Down study estimated that the TARQ allele accounts for 7 % of ARQ alleles in 41 UK sheep flocks examined. The TARQ allele made up 18.6 % of the ARQ alleles present in the Suffolk sheep from the VLA (36 of 194 alleles) and 15.2 % of the randomly selected animals sequenced at INRA (seven of 46 alleles). Our findings may be biased by a founder effect in the New Zealand-derived flocks. However, a much higher prevalence of 31.6 % TARQ alleles in Chinese Suffolk sheep has been reported (Zhang et al., 2004Down).

Scrapie resistance in orally challenged TARQ/TARQ sheep and extended survival times in MARQ/TARQ sheep have been reported previously (Laegreid et al., 2008Down). We have also observed an extended incubation period in MARQ/TARQ sheep (590±41 days p.i.) compared with MARQ/MARQ sheep (372±95 days p.i.) after IC inoculation with the Langlade scrapie strain (O. Andréoletti, unpublished data). Our study is the first to report the association between apparent BSE resistance and the ovine PRNP TARQ allele. However, it is possible that the MARQ/TARQ sheep are susceptible but asymptomatic, or are displaying an increased incubation period.

Laegreid et al. (2008)Down reported a median survival time of 1157 days in MARQ/TARQ sheep challenged orally with scrapie. Six of the MARQ/TARQ sheep challenged orally with bovine BSE in our study have survived beyond this period, with one animal still alive at 3495 days p.i. (Table 1Up). One of the six, culled at 2397 days p.i., displayed no clinical or diagnostic signs of BSE, suggesting that the TARQ-carrying resistant sheep are not asymptomatic carriers of the infection, as reported previously in sheep with apparently resistant genotypes (Ronzon et al., 2006Down). However, long incubation periods should not be interpreted as absolute resistance; therefore, confirmation by mouse bioassay and examination of a wider range of tissues is required to substantiate this finding. Furthermore, three of the six MARQ/TARQ sheep, alive at 3495, 2310 and 2310 days p.i., have survived beyond the longest incubation period of orally BSE-dosed VRQ/VRQ sheep (1825 days p.i.) (Bellworthy et al., 2008Down).

It is interesting to note that the highly effective IC route of challenge, which, with a dose of 0.1 g, shortens the incubation period of bovine and ovine BSE in MARQ/MARQ sheep compared with the incubation period of a 5 g oral dose (Fig. 1Up), does not overcome the transmission barrier of TARQ-carrying sheep challenged with bovine or ovine BSE in our study. The apparent resistance of ARR/ARR sheep to bovine BSE was first overcome by IC challenge, resulting in incubation periods of 1008–1127 days p.i. (Houston et al., 2003Down). These incubation periods are approximately equivalent to the current incubation periods of two bovine BSE IC-challenged (1490 days p.i.) and two ovine BSE IC-challenged (1094 days p.i.) MARQ/TARQ sheep still alive in our study at the time of writing.

In vitro, the TARQ PrPC protein was found to convert poorly (Bossers et al., 2000Down) and recombinant TARQ PrPC proteins exhibited less β-sheet formation than MARQ PrP when exposed to copper (Yang et al., 2008Down), suggesting that MARQ PrPC may be converted more readily to pathogenic PrPSc than TARQ PrPC.

Although the number of animals within an individual BSE-challenge group is small, by combining data from several studies, we have consistently found that the TARQ allele exhibits a protective effect on the transmission of BSE to sheep. Furthermore, animals carrying at least one TARQ allele have so far been resistant to ongoing challenges to assess ‘natural’ sheep-to-sheep BSE transmission after exposure to BSE-infected sheep at both the VLA (Bellworthy et al., 2005bDown) and INRA (F. Lantier, P. Berthon, I. Lantier & O. Andréoletti, unpublished data).

Another ovine PRNP ARQ allele with a proline-to-leucine variant at codon 168 (ARL168Q) has been reported to increase resistance to experimental intravenous inoculation with bovine BSE and exposure via blood transfusion from sheep infected with BSE (Goldmann et al., 2006Down). Our report emphasizes further the importance of obtaining the full ORF sequence of the ovine PRNP gene when studying the transmission of TSEs, and supports previous reports that PrP variants other than the commonly reported 136, 154 and 171 codons can modulate resistance and susceptibility to different TSE strains in sheep (Moum et al., 2005Down; Goldmann et al., 2006Down; Laegreid et al., 2008Down). Such information can inform risk assessments of BSE in sheep, breeding for resistance to scrapie and BSE in sheep, and the design and interpretation of experimental TSE-challenge data.


   ACKNOWLEDGEMENTS
 
Dr Hugh Simmons and all staff involved with Defra project SE1931 are gratefully acknowledged for the breeding and provision of TSE-free animals. Special thanks are due to the staff of the Animal Services Unit, Neuropathology, and David Everest for organizing tissue samples at VLA, UK. Special thanks are also due to the PFIE platform (INRA, Nouzilly, France) for taking care of the animals at containment level 3, performing the IC inoculations and participation in autopsies and for the excellent technical assistance of C. Barc, H. Leroux and C. Rossignol. This study was funded by Defra, UK (projects SE1929, SE1946, SE1846 and SE1945), French GIS prion and the EU Fifth framework project QLK3-CT-2002-1309, led by O. A.


   REFERENCES
TOP
ABSTRACT
MAIN TEXT
REFERENCES
 
Andréoletti, O., Morel, N., Lacroux, C., Rouillon, V., Barc, C., Tabouret, G., Sarradin, P., Berthon, P., Bernardet, P. & other authors (2006). Bovine spongiform encephalopathy agent in spleen from an ARR/ARR orally exposed sheep. J Gen Virol 87, 1043–1046.[Abstract/Free Full Text]

Babar, M. E., Farid, A., Benkel, B. F., Ahmad, J., Nadeem, A. & Imran, M. (2009). Frequencies of PrP genotypes and their implication for breeding against scrapie susceptibility in nine Pakistani sheep breeds. Mol Biol Rep 36, 561–565.[CrossRef][Medline]

Baylis, M. (2002). The BSE-susceptible proportion of UK sheep. Vet Rec 151, 481–482.[Free Full Text]

Bellworthy, S. J., Hawkins, S. A., Green, R. B., Blamire, I., Dexter, G., Dexter, I., Lockey, R., Jeffrey, M., Ryder, S. & other authors (2005a). Tissue distribution of bovine spongiform encephalopathy infectivity in Romney sheep up to the onset of clinical disease after oral challenge. Vet Rec 156, 197–202.[Abstract]

Bellworthy, S. J., Dexter, G., Stack, M., Chaplin, M., Hawkins, S. A., Simmons, M. M., Jeffrey, M., Martin, S., Gonzalez, L. & other authors (2005b). Natural transmission of BSE between sheep within an experimental flock. Vet Rec 157, 206[Free Full Text]

Bellworthy, S. J., Dexter, G., Stack, M., Chaplin, M., Hawkins, S. A., Simmons, M. M., Jeffrey, M., Martin, S., Gonzalez, L. & other authors (2008). Oral transmission of BSE to VRQ/VRQ sheep in an experimental flock. Vet Rec 162, 130–131.[Free Full Text]

Bossers, A., de Vries, R. & Smits, M. A. (2000). Susceptibility of sheep for scrapie as assessed by in vitro conversion of nine naturally occurring variants of PrP. J Virol 74, 1407–1414.[Abstract/Free Full Text]

Bruce, M. E., Will, R. G., Ironside, J. W., McConnell, I., Drummond, D., Suttie, A., McCardle, L., Chree, A., Hope, J. & other authors (1997). Transmissions to mice indicate that ‘new variant’ CJD is caused by the BSE agent. Nature 389, 498–501.[CrossRef][Medline]

Collinge, J., Sidle, K. C., Meads, J., Ironside, J. & Hill, A. F. (1996). Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature 383, 685–690.[CrossRef][Medline]

Eloit, M., Adjou, K., Coulpier, M., Fontaine, J. J., Hamel, R., Lilin, T., Messiaen, S., Andréoletti, O., Baron, T. & other authors (2005). BSE agent signatures in a goat. Vet Rec 156, 523–524.[Free Full Text]

Ferguson, N. M., Ghani, A. C., Donnelly, C. A., Hagenaars, T. J. & Anderson, R. M. (2002). Estimating the human health risk from possible BSE infection of the British sheep flock. Nature 415, 420–424.[CrossRef][Medline]

Foster, J. D., Parnham, D. W., Hunter, N. & Bruce, M. (2001a). Distribution of the prion protein in sheep terminally affected with BSE following experimental oral transmission. J Gen Virol 82, 2319–2326.[Abstract/Free Full Text]

Foster, J. D., Parnham, D., Chong, A., Goldmann, W. & Hunter, N. (2001b). Clinical signs, histopathology and genetics of experimental transmission of BSE and natural scrapie to sheep and goats. Vet Rec 148, 165–171.[Abstract/Free Full Text]

Fryer, H. R., Baylis, M., Sivam, K. & McLean, A. R. (2007). Quantifying the risk from ovine BSE and the impact of control strategies. Proc Biol Sci 274, 1497–1503.[Abstract/Free Full Text]

Gavier-Widén, D., Stack, M. J., Baron, T., Balachandran, A. & Simmons, M. (2005). Diagnosis of transmissible spongiform encephalopathies in animals: a review. J Vet Diagn Invest 17, 509–527.[Abstract/Free Full Text]

Goldmann, W., Hunter, N., Smith, G., Foster, J. & Hope, J. (1994). PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J Gen Virol 75, 989–995.[Abstract/Free Full Text]

Goldmann, W., Baylis, M., Chihota, C., Stevenson, E. & Hunter, N. (2005). Frequencies of PrP gene haplotypes in British sheep flocks and the implications for breeding programmes. J Appl Microbiol 98, 1294–1302.[CrossRef][Medline]

Goldmann, W., Houston, F., Stewart, P., Perucchini, M., Foster, J. & Hunter, N. (2006). Ovine prion protein variant A136R154L168Q171 increases resistance to experimental challenge with bovine spongiform encephalopathy agent. J Gen Virol 87, 3741–3745.[Abstract/Free Full Text]

Gombojav, A., Ishiguro, N., Horiuchi, M. & Shinagawa, M. (2004). Unique amino acid polymorphisms of PrP genes in Mongolian sheep breeds. J Vet Med Sci 66, 1293–1295.[CrossRef][Medline]

Heaton, M. P., Leymaster, K. A., Freking, B. A., Hawk, D. A., Smith, T. P., Keele, J. W., Snelling, W. M., Fox, J. M., Chitko-McKown, C. G. & other authors (2003). Prion gene sequence variation within diverse groups of U.S. sheep, beef cattle, and deer. Mamm Genome 14, 765–777.[CrossRef][Medline]

Hill, A. F., Desbruslais, M., Joiner, S., Sidle, K. C., Gowland, I., Collinge, J., Doey, L. J. & Lantos, P. (1997). The same prion strain causes vCJD and BSE. Nature 389, 448–450.[CrossRef][Medline]

Houston, F., Foster, J. D., Chong, A., Hunter, N. & Bostock, C. J. (2000). Transmission of BSE by blood transfusion in sheep. Lancet 356, 999–1000.[CrossRef][Medline]

Houston, F., Goldmann, W., Chong, A., Jeffrey, M., González, L., Foster, J., Parnham, D. & Hunter, N. (2003). Prion diseases: BSE in sheep bred for resistance to infection. Nature 423, 498[CrossRef][Medline]

Hunter, N. (2003). Scrapie and experimental BSE in sheep. Br Med Bull 66, 171–183.[Abstract/Free Full Text]

Ikeda, T., Horiuchi, M., Ishiguro, N., Muramatsu, Y., Kai-Uwe, G. D. & Shinagawa, M. (1995). Amino acid polymorphisms of PrP with reference to onset of scrapie in Suffolk and Corriedale sheep in Japan. J Gen Virol 76, 2577–2581.[Abstract/Free Full Text]

Jeffrey, M., Ryder, S., Martin, S., Hawkins, S. A., Terry, L., Berthelin-Baker, C. & Bellworthy, S. J. (2001). Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol 124, 280–289.[CrossRef][Medline]

Jeffrey, M., Martin, S., González, L., Foster, J., Langeveld, J. P., van Zijderveld, F. G., Grassi, J. & Hunter, N. (2006). Immunohistochemical features of PrPd accumulation in natural and experimental goat transmissible spongiform encephalopathies. J Comp Pathol 134, 171–181.[CrossRef][Medline]

Kao, R. R., Gravenor, M. B., Baylis, M., Bostock, C. J., Chihota, C. M., Evans, J. C., Goldmann, W., Smith, A. J. & McLean, A. R. (2002). The potential size and duration of an epidemic of bovine spongiform encephalopathy in British sheep. Science 295, 332–335.[Abstract/Free Full Text]

Kao, R. R., Houston, F., Baylis, M., Chihota, C. M., Goldmann, W., Gravenor, M. B., Hunter, N. & McLean, A. R. (2003). Epidemiological implications of the susceptibility to BSE of putatively resistant sheep. J Gen Virol 84, 3503–3512.[Abstract/Free Full Text]

Laegreid, W. W., Clawson, M. L., Heaton, M. P., Green, B. T., O'Rourke, K. I. & Knowles, D. P. (2008). Scrapie resistance in ARQ sheep. J Virol 82, 10318–10320.[Abstract/Free Full Text]

Lan, Z., Wang, Z. L., Liu, Y. & Zhang, X. (2006). Prion protein gene (PRNP) polymorphisms in Xinjiang local sheep breeds in China. Arch Virol 151, 2095–2101.[CrossRef][Medline]

Laplanche, J. L., Chatelain, J., Westaway, D., Thomas, S., Dussaucy, M., Brugere-Picoux, J. & Launay, J. M. (1993). PrP polymorphisms associated with natural scrapie discovered by denaturing gradient gel electrophoresis. Genomics 15, 30–37.[CrossRef][Medline]

Moum, T., Olsaker, I., Hopp, P., Moldal, T., Valheim, M., Moum, T. & Benestad, S. L. (2005). Polymorphisms at codons 141 and 154 in the ovine prion protein gene are associated with scrapie Nor98 cases. J Gen Virol 86, 231–235.[Abstract/Free Full Text]

Ohara, J., Togari, T., Kurokawa, A., Maeda, J., Ishiguro, N., Furuoka, H. & Horiuchi, M. (2007). Frequencies of PrP genotypes in meat breeds of Japanese sheep and trail of selective breeding in experimental sheep flock. J Vet Med Sci 69, 1325–1329.[CrossRef][Medline]

Prusiner, S. B. (1982). Novel proteinaceous particles cause scrapie. Science 216, 136–144.[Abstract/Free Full Text]

Ronzon, F., Bencsik, A., Lezmi, S., Vulin, J., Kodjo, A. & Baron, T. (2006). BSE inoculation to prion diseases-resistant sheep reveals tricky silent carriers. Biochem Biophys Res Commun 350, 872–877.[CrossRef][Medline]

Saunders, G. C., Cawthraw, S., Mountjoy, S., Hope, J. & Windl, O. (2006). PrP genotypes of atypical scrapie cases in Great Britain. J Gen Virol 87, 3141–3149.[Abstract/Free Full Text]

Saunders, G. C., Cawthraw, S., Mountjoy, S. J., Tout, A. C., Sayers, A. R., Hope, J. & Windl, O. (2009). Ovine PRNP untranslated region and promoter haplotype diversity. J Gen Virol 90, 1289–1293.[Abstract/Free Full Text]

Serrano, C., Martín-Burriel, I., Lyahyai, J., Monzón, M., El Hamidi, M., Acín, C., Badiola, J. J., Tligui, N. & Zaragoza, P. (2007). Polymorphisms of the PRNP gene in Moroccan sheep breeds. Vet Rec 161, 524–525.[Free Full Text]

Sharpe, A., McElroy, M., Langeveld, J. P., Bassett, H., O'Donoghue, A. M. & Sweeney, T. (2005). Immunohistochemical studies of scrapie archival material from Irish ARQ/ARQ sheep for evidence of bovine spongiform encephalopathy-derived disease. Res Vet Sci 79, 29–35.[CrossRef][Medline]

Simmons, M. M., Konold, T., Simmons, H. A., Spencer, Y. I., Lockey, R., Spiropoulos, J., Everitt, S. & Clifford, D. (2007). Experimental transmission of atypical scrapie to sheep. BMC Vet Res 3, 20[CrossRef][Medline]

Simmons, H. A., Simmons, M. M., Spencer, Y. I., Chaplin, M. J., Povey, G., Davis, A., Ortiz-Pelaez, A., Hunter, N., Matthews, D. & other authors (2009). Atypical scrapie in sheep from a UK research flock which is free from classical scrapie. BMC Vet Res 5, 8[CrossRef][Medline]

Stack, M., Jeffrey, M., Gubbins, S., Grimmer, S., González, L., Martin, S., Chaplin, M., Webb, P., Simmons, M. & other authors (2006). Monitoring for bovine spongiform encephalopathy in sheep in Great Britain, 1998–2004. J Gen Virol 87, 2099–2107.[Abstract/Free Full Text]

Thuring, C. M., Erkens, J. H, Jacobs, J. G., Bossers, A., Van Keulen, L. J., Garssen, G. J., Van Zijderveld, F. G., Ryder, S. J., Groschup, M. H. & other authors (2004). Discrimination between scrapie and bovine spongiform encephalopathy in sheep by molecular size, immunoreactivity, and glycoprofile of prion protein. J Clin Microbiol 42, 972–980.[Abstract/Free Full Text]

Vaccari, G., D'Agostino, C., Nonno, R., Rosone, F., Conte, M., Di Bari, M. A., Chiappini, B., Esposito, E., De Grossi, L. & other authors (2007). Prion protein alleles showing a protective effect on the susceptibility of sheep to scrapie and bovine spongiform encephalopathy. J Virol 81, 7306–7309.[Abstract/Free Full Text]

van Keulen, L. J., Vromans, M. E., Dolstra, C. H., Bossers, A. & van Zijderveld, F. G. (2008). Pathogenesis of bovine spongiform encephalopathy in sheep. Arch Virol 153, 445–453.[CrossRef][Medline]

Ward, H. J., Everington, D., Cousens, S. N., Smith-Bathgate, B., Leitch, M., Cooper, S., Heath, C., Knight, R. S., Smith, P. G. & other authors (2006). Risk factors for variant Creutzfeldt–Jakob disease: a case–control study. Ann Neurol 59, 111–120.[CrossRef][Medline]

Wells, G. A. H., Scott, A. C., Johnson, C. T., Gunning, R. F., Hancock, R. D., Jeffrey, M., Dawson, M. & Bradley, R. (1987). A novel progressive spongiform encephalopathy in cattle. Vet Rec 121, 419–420.[Medline]

Wells, G. A. H., Konold, T., Arnold, M. E., Austin, A. R., Hawkins, S. A. C., Stack, M., Simmons, M. M., Lee, Y. H., Gavier-Widén, D. & other authors (2007). Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle. J Gen Virol 88, 1363–1373.[Abstract/Free Full Text]

Wilesmith, J. W., Ryan, J. B. & Hueston, W. D. (1992). Bovine spongiform encephalopathy: case–control studies of calf feeding practices and meat and bonemeal inclusion in proprietary concentrates. Res Vet Sci 52, 325–331.[Medline]

Will, R. G., Ironside, J. W., Zeidler, M., Cousens, S. N., Estibeiro, K., Alperovitch, A., Poser, S., Pocchiari, M., Hofman, A. & other authors (1996). A new variant of Creutzfeldt–Jakob disease in the UK. Lancet 347, 921–925.[CrossRef][Medline]

Yang, S., Thackray, A. M., Fitzmaurice, T. J. & Bujdoso, R. (2008). Copper-induced structural changes in the ovine prion protein are influenced by a polymorphism at codon 112. Biochim Biophys Acta 1784, 683–692.[Medline]

Zhang, L., Li, N., Fan, B., Fang, M. & Xu, W. (2004). PRNP polymorphisms in Chinese ovine, caprine and bovine breeds. Anim Genet 35, 457–461.[CrossRef][Medline]

Received 16 April 2009; accepted 6 July 2009.



This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Supplementary table
Right arrow All Versions of this Article:
vir.0.012724-0v1
90/10/2569    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Saunders, G. C.
Right arrow Articles by Lantier, F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saunders, G. C.
Right arrow Articles by Lantier, F.
Agricola
Right arrow Articles by Saunders, G. C.
Right arrow Articles by Lantier, F.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS